Developing
the
first screening test for Stomach Cancer

With only a blood sample, our test can detect early-stage gastric cancer, even before symptoms appear.

  • Stomach Cancer is the 5th most common cancer worldwide. While it’s more prevalent in certain regions, such as East Asia, it can affect people everywhere.

  • While stomach cancer is more common in people over 60, it can occur at any age. Younger individuals are not immune to stomach cancer, especially if they have risk factors like H. pylori infection, smoking, or a diet high in salty and smoked foods.

  • Stomach cancer often starts with subtle symptoms like indigestion, mild nausea, or a feeling of fullness after eating small amounts. These can easy be mistaken for common digestive issues. More obvious symptoms however like vomiting, weight loss, or severe pain appear, the cancer may be more advanced.

  • Stomach cancer can be treated effectively, especially when caught early. Advances in medical technology and treatment options have improved survival rates significantly. Early detection and prompt treatment can lead to positive outcomes, so it’s important to watch for symptoms and seek medical advice if you notice anything unusual.

Our test:

  • Reduce treatment costs by 90%, compared to advanced stage treatments

  • Timely results to prioritize patients at risk (“fast track”)

  • Screening potential due to its low cost and ease of implementation

  • Monitoring capacity for the dynamic follow-up of premalignant lesions (i.e., gastric intestinal metaplasia or “GIM”)

Our Collaborators

Our Investors